Health

Results: 13-24 of 5768

Incyte Announces FDA Approval of Monjuvi® (tafasitamab-cxix) in Combination with Rituximab and Lenalidomide for Patients with Relapsed or Refractory Follicular Lymphoma

PR Newswire associated0

Backed by $2 Million, Droplet IV is Set to Launch its Revolutionary Automatic IV-Line Flushing Device in EU & US in 2026

Rabies case confirmed following contact with animal abroad

PR Newswire associated0

Medison Expands Global Leadership Team with Chief Business Officer and Chief Legal & Compliance Officer

Neoclease receives Merck’s North American Advance Biotech Grant.

Merck Announces Neoclease as Winner of 2025 North American Advance Biotech Grant

Embla Medical Recognized for Leadership in Accessibility and International Reach

SINOVAC Announces New Board Member

PR Newswire associated0

Peer-Reviewed Study in Nature Scientific Reports Demonstrates Non-Invasive Fat Reduction Using Alma's Energy-Based Technology

Work-Life Balance Matters More Than Pay for Many UK Doctors, Medscape Survey Reveals

Camurus' POSITANO study shows treatment effects with CAM2029 in polycystic liver disease patients

Oncoinvent Announces Positive Final Data from Phase 1/2a Trial of Radspherin® in Patients with Colorectal Peritoneal Metastases

ICD 2025: New data demonstrate Nemluvio®’s (nemolizumab) favorable safety profile and sustained and clinically meaningful improvements in symptoms of prurigo nodularis up to two years